
Mild elution releases antibodies from a Protein A resin at a gentler pH (e.g., 4.5–5.0) than conventional resins, which typically elute at pH 3.0–4.0 and can cause antibody aggregation, denaturation and activity loss. The Nexligos™ Protein A series from Matwings Technology covers mild-elution and alkali-resistant needs; Protein A ME keeps recovery above 85% at pH 5.0, giving pH-sensitive antibodies a more robust capture route.
November 15, 2026
The CH3 (VHH) affinity resin captures the CH3 constant domain of Fc. It is independent of CH2 glycosylation and of the classic Protein A epitope, so it can purify Fc-missing constructs, engineered Fc variants, and certain bispecific antibodies that are missed by Protein A workflows.
November 12, 2026.jpg&w=3840&q=75)
An AI Autonomous Laboratory (also known as a “lights-out laboratory”) uses a conversational agent as the brain and strings an automated line into a Design–Validate–Iterate dry-wet loop, compressing the protein R&D cycle from 3–5 years to 2–6 months and lifting the hit rate from below 5% to above 40%. This article explains its autonomy, the full solution, and the three automation platforms.
November 12, 2026
Alkali-resistant Protein A affinity resin is the core capture media for mAbs and Fc-fusion proteins. Matwings Technology’s Nexligos™ series uses an engineered recombinant Protein A ligand designed by the protein R&D agent MatwingsVenus®, raising alkali stability while retaining high binding capacity — in-place cleaning across 0.1–1.0 M NaOH and different elution-pH options by alkali strength. Because binding capacity, NaOH tolerance, elution pH and molecule range differ, selection depends on process needs. This article compares three Nexligos™ alkali-resistant media and how to choose.
November 12, 2026
① Matwings Technology has accumulated tens of billions of protein sequence entries, 6.7 billion of which carry functional annotations. The dataset has been selected among the first batch of national high-quality dataset exemplars. ② Shanghai’s strengths come down to three things: a high density of talent, courageous capital, and abundant application scenarios. Together, they give the city a strikingly strong advantage in developing AI biomedicine and AI biomanufacturing.
November 18, 2026
The semaglutide P29 peptide is the 29-residue main chain of semaglutide, and it is the building block that decides the cost, purity and consistency of the downstream process. This article explains what the P29 intermediate is, compares the chemical and fermentation routes, maps the production workflow, and sets out the quality and selection criteria for choosing a semaglutide P29 peptide supplier.
November 18, 2026
This report introduces Matwsings Technology (MatwingsVenus), a Chinese AI protein engineering company, and its technical approach of “skipping structure and directly learning function.” In response to Anthropic’s September 2026 global protein design competition, which was not open to Chinese teams, Hong Liang and others assembled scientists from nine top universities and national laboratories to launch the “Yangtze River Cup” challenge, open to the world, providing free wet-lab validation of 7,000 proteins. The article shows that since 2022 the company has used massive functional label data to train large models and directly learn the “sequence-to-function” mapping, treating proteins as paragraphs for “reading comprehension.” Its model, VenusREM, is reportedly ranked first in Harvard’s PG-LLM evaluation with ρ = 0.523 among 95 specialized models and 13 general-purpose large models. Commercially, Tianwu is driven by a dual-wheel model of “platform technology + underlying products,” landing in scenarios such as PET-degrading enzymes, innovative drugs, and industrial enzymes, and has launched the conversational dry-wet combined protein design agent MatwingsVenus® (Xiaowu®). On the capital side, it has received a cumulative 42 million yuan investment from the Shanghai Guotou system, plus an A+ round of over 200 million yuan and an A++ round of several hundred million yuan in succession; on the talent side, it relies on Shanghai’s “Hundred Teams, Hundred Projects” special program, focusing on interdisciplinary young scientists.
November 17, 2026
The Semaglutide P29 peptide intermediate, also known as the semaglutide 29-peptide backbone or Arg34GLP-1(9-37) (CAS 1169630-82-3), is the 29-amino-acid chain that defines the identity of semaglutide and drives most of its downstream quality. How it is made determines the purity, impurity profile, and batch consistency you start from. This guide explains the structure, walks through the fermentation route of recombinant expression, enzyme digestion, and medium-pressure chromatography, and sets out how to judge the quality of the intermediate and its companion enzymes.
November 10, 2026
Semaglutide, a long-acting GLP-1 receptor agonist, is built on a 29-residue main chain that intermediates supply as the semaglutide intermediate P29 (Arg34 GLP-1(9-37)). This article compares chemical synthesis with enzymatic/recombinant routes for producing that chain, explains how recombinant enterokinase, Kex2 protease, carboxypeptidase B, trypsin and TEV release and clean the peptide, and frames the yield, cost and purity trade-offs that drive route selection for research, pilot and industrial GMP manufacture.
November 10, 2026
An automated protein research platform connects protein design, build, screening, and characterization into a data-driven closed loop, helping teams shorten R&D cycles, lower costs, and improve reproducibility. Starting from R&D pain points, this article explains how the Design–Build–Test–Learn loop works, where AI and automation genuinely help, and which lab conditions are needed. It then introduces how MatwingsVenus® deploys automation in protein engineering, offering actionable guidance for enzyme engineering, antibody optimization, and protein directed evolution.
November 10, 2026
A protein agent (Protein Agent) is an AI system centered on a task goal that perceives protein data, decomposes objectives, and calls design / prediction / screening tools — chaining “computational design → automated experiment → data feedback → re-design” into a closed loop. It shifts protein R&D from expert intuition and mass trial-and-error toward a conversational, iterable intelligent workflow. This article explains its background, mechanism, selection and deployment, and how MatwingsVenus®(晓鹜®)delivers a “conversational dry-wet closed loop”.
November 10, 2026
A protein design agent is a conversational protein R&D tool built around an AI agent that uses natural language to drive sequence design, structure prediction, enzyme mining, and experimental validation. This article begins with the bottlenecks of traditional protein R&D, explains the agent's concept and capability boundaries, and introduces MatwingsVenus®'s positioning, core capabilities, and wet-dry closed-loop paradigm, followed by applicable scenarios, objective limitations, and selection guidance.
November 10, 2026
Horseradish Peroxidase (HRP; EC 1.11.1.7) is a heme-containing glycoprotein tool enzyme from the roots of horseradish (Armoracia rusticana). Using hydrogen peroxide as oxidant, it oxidizes a range of donor substrates into colored or luminescent products, making it the most widely used enzyme label in immunodetection: ELISA, immunohistochemistry, immunoblotting and biosensors all rely on it. This article moves from the "signal amplifier" analogy into its heme catalytic core, calcium-stabilized structure, the three-step catalytic cycle from Compound I to Compound II, influencing factors and engineering directions, then to industrial adaptation and selection logic, with a brief transition to MATWINGS MALL custom tool-enzyme development. It serves both general readers and technical R&D/procurement staff.
November 9, 2026
BRENDA enzyme activity data querying is a foundational step in enzymology and industrial biocatalysis. This article introduces the role and data taxonomy of BRENDA (Braunschweig Enzyme Database), walks through common routes for retrieving Km, kcat, Ki, IC50 and optimal pH/temperature using EC number, substrate or organism, explains how these kinetic parameters inform enzyme engineering and process-condition design, and closes with how MatwingsVenus® (Xiaowu) helps teams turn activity data into verifiable experimental and production steps.
November 9, 2026
Clustal Omega is the next-generation multiple sequence alignment (MSA) tool in the Clustal family, designed for large-scale protein sequences. It builds a guide tree with mBed and aligns profile-HMMs with HHalign, balancing speed and accuracy. Compared with ClustalW, Clustal Omega handles thousands of sequences and is commonly used for conserved-residue identification, domain annotation and evolutionary analysis. This article explains its core principles, applicable boundaries and practical usage, and how it supports protein engineering workflows.
November 9, 2026
MAFFT (Multiple Alignment using Fast Fourier Transform) is an efficient multiple sequence alignment algorithm introduced by Katoh and colleagues at Osaka University in 2002. It uses the FFT to locate homologous regions quickly and balances speed with accuracy through progressive alignment and iterative refinement, making it a staple upstream step for phylogenetics, conserved-site detection, and protein engineering. This article explains MAFFT's five-step pipeline, strategy selection (L-INS-i, FFT-NS-2, etc.), and key parameters, and how its alignment supplies evolutionary priors to AI protein engineering.
November 9, 2026
This is a Pfam domain query tutorial for scientists and industrial protein-engineering users: it starts from the idea that proteins are built from domains, introduces the Pfam/InterPro families, HMM models and the Clan system, then walks you through mapping domains such as SH3–SH2–Kinase from a single sequence via InterProScan/HMMER, interpreting E-values, coverage and entry types, and finally applies it to protein engineering with the MatwingsVenus® dry–wet closed loop.
November 9, 2026
Alkaline Phosphatase (ALP; EC 3.1.3.1) is a class of enzymes that hydrolyze phosphomonoesters at alkaline pH, effectively removing phosphate groups from substrates. It dephosphorylates vector 5' ends in molecular cloning to prevent recircularization and improve positive clone yields, and it serves as a high-sensitivity reporter label in immunoassays and blot development. It is also measured in clinical chemistry for hepatobiliary and bone-metabolism related markers.
November 9, 2026.png&w=3840&q=75)
InterPro protein function analysis integrates signatures from multiple member databases to identify protein families, domains and functional sites, serving as a trustworthy bridge between sequence annotation and downstream wet-lab validation.
November 8, 2026
Glucocerebrosidase (EC 3.2.1.45, also called acid beta-glucosidase, GBA/GCase) is a lysosomal membrane-associated exo-beta-glucosidase that hydrolyzes glucosylceramide into glucose and ceramide. Its activity depends on the activator protein saposin C and negatively charged lipids, with an optimal pH near 5.5 and a retaining hydrolysis mechanism. GBA1 deficiency causes glucosylceramide accumulation in macrophages, leading to Gaucher disease. Enzyme replacement therapy (ERT) supplies recombinant enzyme intravenously to reduce lipid accumulation; representative products are imiglucerase, velaglucerase alfa and taliglucerase alfa. For R&D and procurement, the core is to bring expression system, glycoengineering, immunogenicity, activity and batch consistency into one evaluation framework.
November 8, 2026
Foldseek is a tool that performs fast protein structure search by encoding 3D structures into searchable strings using its 3Di structural alphabet, scanning millions of structures within seconds. Compared with classic structural aligners (TM-align, Dali, CE), Foldseek reduces computation time by four to five orders of magnitude while retaining 86% of Dali's, 88% of TM-align's, and 133% of CE's sensitivity. This guide explains the principle, the speed and sensitivity benchmarks, installation and command-line usage, technical selection, and practical tips for Foldseek structure search, and how it can be combined with a protein engineering platform for remote homology detection, function annotation, and design loops.
November 8, 2026
MMseqs2 sequence search is an open-source algorithm for ultra-large-scale protein sequence comparison and clustering, quickly identifying homologs in massive databases. This article explains its two-stage workflow, k-mer prefiltering combined with vectorized Smith-Waterman alignment, and how it trades speed against sensitivity; it also covers how to choose the right search mode by sequence scale and task, and how it fits into AI-driven protein discovery and engineering pipelines for homolog mining, deduplication, and template selection.
November 8, 2026.png&w=3840&q=75)
This article explains the complete PDB protein structure download workflow: from understanding RCSB PDB and PDB/mmCIF structure files, to the three retrieval routes (web search, REST/GraphQL API, batch download), to quality validation (resolution, B-factor, missing residues) and structure preparation. It is written for real applications in molecular docking, molecular dynamics, AI protein design, and enzyme/antibody engineering, helping researchers turn reliable structure data into a stable engineering starting point.
November 8, 2026
Collagenase (EC 3.4.24.3) is a protease that hydrolyzes native collagen in its triple-helical conformation under physiological conditions, mainly from Clostridium histolyticum. It cleaves X–Gly peptide bonds in the triple helix, breaking a dense collagen network into small fragments. Clinically, clostridial collagenase is used for enzymatic debridement of chronic ulcers and burns (e.g., SANTYL ointment) and for intralesional injection in Dupuytren's contracture and Peyronie's disease (Xiaflex); in bioprocessing it is used for pancreatic islet isolation and tissue dissociation. Selection should center on cleavage site, metal dependence, pH window, activity assay and batch consistency.
November 8, 2026
Deoxyribonuclease I (DNase I) is an endonuclease that specifically hydrolyzes the phosphodiester bonds of DNA, cleaving long DNA backbones into short fragments. Recombinant human DNase I (dornase alfa, Pulmozyme) degrades extracellular DNA in the airways of cystic fibrosis patients by nebulized inhalation, reducing sputum viscosity; it was approved in 1994. In laboratory and industrial bioprocessing, DNase I clears genomic DNA from cell lysates, lowering viscosity and preparing the stream for downstream purification. Selection should combine specific activity, nuclease contamination, batch consistency and divalent-cation compatibility in one evaluation framework.
November 8, 2026.png&w=3840&q=75)
This article on protein language model research explains how protein language models (PLMs) work—treating amino acid sequences as a "language" for self-supervised pretraining—their capability boundaries in structure prediction, function annotation and fitness landscapes, the engineering prerequisites for deployment, and how MatwingsVenus® (Xiaowu®) empowers such research through a wet-lab–in-silico closed loop. Written for researchers and decision makers in protein engineering, enzyme engineering, antibody discovery and AI-driven computational biology.
November 8, 2026
HMMER protein search lets researchers turn a single sequence or a multiple sequence alignment into a position-specific profile HMM, then mine massive protein databases for homologous sequences and family members. Unlike classic pairwise alignment, a profile HMM captures which positions are conserved and which are variable across a family, making it much more sensitive to distant homologs, and it reports statistical significance through an E-value. Knowing how hmmsearch, hmmscan, phmmer and jackhmmer differ, and choosing the right database and thresholds, is the key to using this standard bioinformatics tool well. This article breaks down the principle, workflow and selection, and shows its role in AI-driven protein engineering.
November 8, 2026
An AI protein laboratory refers to an AI-centric R&D paradigm that connects protein design, structure prediction, performance evaluation, and wet-lab validation into a "dry–wet closed loop." Built on the Design–Build–Test–Learn (DBTL) cycle, it uses generative models (e.g., RFdiffusion, ProteinMPNN) to produce candidate sequences, structure-prediction models (e.g., AlphaFold) to verify folding, and active learning to feed every wet-lab result back into the model for continuous iteration. Compared with traditional directed evolution, the AI protein laboratory can shrink the search space from astronomical mutation combinations to high-value regions, significantly improving efficiency and success rate. This article explains the principles, closed loop, and applications of the AI protein laboratory, where its boundaries lie, and introduces MatwingsVenus® protein agent's engineering practice.
November 5, 2026
SaProt's structure-aware protein language model "folds 3D structure into the vocabulary," letting the model read local structure beyond sequence — a key step from "sequence-only" to "sequence + structure," with broad gains on variant-effect and stability tasks.
November 5, 2026
BLASTp (Basic Local Alignment Search Tool for proteins) is a classic NCBI tool that compares one protein query sequence against a protein database, proposed by Altschul et al. in 1990. It uses an amino-acid substitution matrix (default BLOSUM62) and a seed-word hit strategy to find similar segments locally, then reports statistical metrics such as the E-value, bit score, and identity to help you judge whether an alignment is significant. With BLASTp you can identify unknown proteins, infer homology and function, and find gene-family members, laying the foundation for functional annotation and gene-family analysis.
November 5, 2026
ESM3 is a frontier generative foundation model for biology released by EvolutionaryScale in June 2024, and the first generative model to simultaneously reason over protein sequence, structure and function. Unlike "predictive" models such as AlphaFold, ESM3 programs proteins like a language model: it encodes sequence, structure and function into a shared representation and then generates new proteins. In its flagship result, chain-of-thought prompting on the chromophore residues produced esmGFP, a new fluorescent protein sharing only ~58% sequence identity with its nearest natural counterpart — equivalent to simulating ~500 million years of evolution — and validated by wet-lab fluorescence measurement. This article explains ESM3's mechanism, capability boundaries, evaluation, and the design–synthesize–test–learn dry-wet closed loop, and how MatwingsVenus®(晓鹜®)connects such generative models into an actionable experimental loop.
November 5, 2026
The NCBI Protein Database is a public resource for retrieving protein sequences and annotation, aggregating translations from annotated coding regions in GenBank, RefSeq reference sequences and TPA third-party annotation, with cross-links to UniProt, PDB, PubMed and Gene/Taxonomy. This article explains in plain language how it organizes protein information—from sequence sources and a single record's structure, to the Protein BLAST and CD-Search analysis tools, and onward into protein-engineering pipelines. Whether you need to find a protein sequence quickly or prepare inputs for AI protein design, you can get a clear path and understand its capability boundaries here.
November 5, 2026
The STRING protein-protein interaction database (Search Tool for the Retrieval of Interacting Genes/Proteins) is one of the most widely used public resources for protein-protein interactions (PPI). As of STRING 12.5 it covers about 59.3 million proteins across 12,535 organisms. It aggregates experimental interactions, curated pathway databases, literature text-mining, and computational prediction channels such as gene neighborhood, gene fusion, phylogenetic co-occurrence, and co-expression, then probabilistically combines them into a 0–1 confidence score that tells you how reliable each interaction is. With STRING you can build PPI networks, run pathway enrichment and clustering, and obtain explainable network evidence for target discovery, functional annotation, and mechanistic studies. This article walks you through the principles, scoring, and application workflow of STRING.
November 5, 2026%20%E2%80%94%20the%20Fc%20region%20is%20the%20Protein%20A%20binding%20site.png&w=3840&q=75)
Written for R&D and process teams, this article explains protein language model (PLM) mutation prediction: how PLMs self-supervise on large unlabeled proteomes to encode amino-acid sequences into residue-level embeddings rich in structure and function information, enabling prediction of single-point or combinatorial mutation effects on stability, function and binding affinity. It also covers capability boundaries (wet-lab validation still required), differences versus classical computational methods, and a practical dry-wet closed-loop path for antibody and enzyme engineering.
November 5, 2026
An AI biofoundation model is a general-purpose AI model pre-trained on large-scale protein sequence, structure and function data, and fine-tuned on downstream tasks for structure prediction, function annotation, protein design and property optimization. By replacing the old ‘one task, one model’ approach with a ‘general base + task adaptation’ pattern, it is reshaping protein engineering and drug discovery. This article explains its background, principles, capability limits and selection criteria, and shows how MatwingsVenus®(晓鹜®) platform couples a biofoundation model with a wet-lab validation loop to move from sequence to high-performance proteins.
November 4, 2026
The inverse folding model sets the first quality gate of sequence design — selection should weigh sequence recovery, designability and downstream wet-lab validation cost, not any single metric.
November 4, 2026
KEGG (Kyoto Encyclopedia of Genes and Genomes) is a classic database linking genes to biological function. KEGG protein pathways map genomic, transcriptomic or proteomic data into interpretable metabolic, signaling and disease pathway networks through a three-layer structure: Gene → KO (KEGG Orthology) → Pathway Map.
November 4, 2026.png&w=3840&q=75)
Alteplase (recombinant tissue plasminogen activator, rt-PA) is one of the most widely used thrombolytic drugs and is the gene-engineered version of the tissue plasminogen activator (tPA) produced by vascular endothelium. This article first uses an everyday analogy to explain how tPA converts plasminogen trapped in a clot into plasmin and locally dismantles the fibrin mesh. It then turns to R&D and procurement audiences, covering the generational evolution of fibrinolytic enzyme preparations, the trade-off between fibrin specificity and bleeding risk, half-life and delivery routes, the engineering of glycosylation variants such as tenecteplase, and industrial considerations such as CHO expression, purification and activity assays. It closes with a selection logic for thrombolysis-related enzyme preparations.
November 4, 2026
The CAZy Database (Carbohydrate-Active enZymes Database) is a globally recognized platform for classifying and annotating carbohydrate-active enzymes. By amino-acid sequence homology it groups glycoside hydrolases (GH), glycosyltransferases (GT), polysaccharide lyases (PL), carbohydrate esterases (CE), auxiliary activities (AA) and carbohydrate-binding modules (CBM) into hundreds of families, each of which shares a fold and a catalytic mechanism. This article explains how CAZy classifies enzymes, how to query and annotate them, and how it supports enzyme discovery and engineering in food, feed, biofuel and bio-manufacturing, working alongside AI-driven protein-engineering platforms.
November 4, 2026%20as%20the%20constraint%20to%20reverse-engineer%20amino%20acid%20sequences.png&w=3840&q=75)
Structure-based protein sequence design treats the structure as the constraint, reverse-solves amino acid sequences with AI, and iteratively verifies them in a dry-wet closed loop so that 'designed' proteins truly fold, are stable, and are functional.
November 4, 2026
Streptokinase (SK) and urokinase (uPA) are both plasminogen activators that convert plasminogen into plasmin and dissolve thrombi, making them the two thrombolytic enzymes most often compared in clinics and research. Yet their source, mechanism, immunogenicity, and cost differ greatly. Streptokinase comes from streptococci, is inexpensive, but is prone to causing allergy; urokinase is more human-derived and repeatably dosed but costlier. Using a comparative view, this article moves from application scenarios, mechanism, technical route, process control, to selection, addressing both general readers and R&D and procurement professionals on why the two are alike, why they differ, and how to choose by scenario.
November 4, 2026
The BRENDA enzyme database (BRaunschweig ENzyme DAtabase) is the world’s most comprehensive repository of enzyme functional data. Organized by the Enzyme Commission (EC) nomenclature of the International Union of Biochemistry and Molecular Biology (IUBMB), it stores EC classification, catalyzed reactions, substrates/products, kinetic parameters (Km, Vmax, kcat, kcat/Km), cofactors, inhibitors, optimal pH and temperature, biological source, structure, and stability. Data are manually curated from the primary literature, currently maintained by the Leibniz Institute DSMZ, and recognized as an ELIXIR Core Data Resource; the online version is free under CC BY 4.0. This article explains BRENDA’s content, data structure, query and API usage, and how to combine it with an AI-driven enzyme engineering platform such as MatwingsVenus®(晓鹜®) to close the loop from enzyme selection and condition optimization to directed engineering.
November 4, 2026
Urate oxidase (uricase, EC 1.7.3.3) specifically oxidizes uric acid to allantoin, releasing hydrogen peroxide and carbon dioxide. Humans lost a functional uricase gene in evolution, yet built the mainstream enzymatic uric acid assay on this very reaction. Understanding the catalytic mechanism, source differences and process windows is key to choosing a stable oxidase tool enzyme.
November 4, 2026
LigandMPNN is a deep-learning protein sequence design model published in Nature Methods (2025, Dauparas et al.) that explicitly models all nonprotein components—small molecules, nucleotides and metals. It substantially outperforms Rosetta and ProteinMPNN on native-sequence recovery for ligand-contacting residues and has been used to design over 100 experimentally validated small-molecule and DNA-binding proteins.
November 4, 2026
The AlphaFold Database (AlphaFold DB) is a free protein-structure prediction database jointly developed by Google DeepMind and EMBL-EBI. Powered by the Nobel Prize-winning AlphaFold AI, it maps amino-acid sequences to 3D structures and now hosts more than 200 million AI-predicted protein structures. It provides two quality metrics — pLDDT confidence and PAE — so researchers can quickly shortlist high-confidence structures for drug discovery, enzyme engineering, and antibody design. This article explains, in plain language, how AlphaFold DB works, how to use it, and where its limits lie, and how MatwingsVenus®(晓鹜®) by Matwings Technology connects the database to a protein-engineering loop.
November 4, 2026
A protein foundation model is a large-scale AI model pre-trained with self-supervised learning on massive protein sequence data, enabling it to learn the "language" of proteins for structure prediction, mutation-effect assessment and de novo protein design. This article explains how protein foundation models work, their main capabilities and limitations (e.g. ESM/ESMFold, AlphaFold, ProteinMPNN, RFdiffusion), and how MatwingsVenus® (晓鹜®) — the protein-design general foundation model developed by Matwings Technology — turns an "AI design → automated experiment → data feedback" dry–wet loop into practice, helping researchers and industry shorten R&D cycles and improve success rates.
November 3, 2026
ProteinMPNN protein sequence design lets AI turn a 3D protein backbone into foldable amino-acid sequences, a key step on the path from manual trial-and-error to a compute-design–verify–learn closed loop.
November 3, 2026
The InterPro protein database, maintained by EMBL-EBI, is an authoritative protein resource that integrates protein signatures from 13 member databases including Pfam, SMART, CDD and PANTHER, classifying protein sequences into families, domains, repeats and functional sites. Through a unique IPR entry identifier, name, abstract and GO annotation, it delivers consistent, reusable functional annotations for every protein. Together with the InterProScan tool and the InterPro-N AI model, it covers the vast majority of UniProtKB sequences and is widely used for genome annotation, domain prediction and protein family analysis. This article explains InterPro's mechanism, entry structure, workflow and capability boundaries to help researchers annotate protein function more accurately.
November 3, 2026
This tutorial explains RFdiffusion protein design end to end: the denoising-diffusion principle behind it (built on the RoseTTAFold architecture, adding/removing Gaussian noise on backbone coordinates and residue frames), how it generates de novo backbones, how ProteinMPNN designs amino-acid sequences, how AlphaFold2/Boltz re-folding filters candidates, and how wet-lab expression and binding assays validate them. It also makes the capability boundary explicit: RFdiffusion is a powerful starting point, not an end point, and hit rates depend on target, conditions and control parameters. It closes by describing how MatwingsVenus® (Xiaowu®) fuses such generative models with a high-throughput wet-lab closed loop to turn AI protein design into deliverable molecules.
November 3, 2026
The Pfam protein family database is one of the most widely used resources for protein family and domain annotation, built around profile hidden Markov models (HMMs) that assign protein sequences to thousands of families. Pfam-A entries are manually curated and high quality, while Pfam-B entries are generated by automated clustering; both are integrated through InterPro and UniProt. Researchers use Pfam to identify domain architecture, predict protein function and trace evolutionary origins.
November 3, 2026
beta-Glucan is an anti-nutritional factor in cereal cell walls that raises the viscosity of wort and intestinal digesta, dragging down brewing yield and feed utilization. beta-1,3-1,4-Glucanase (EC 3.2.1.73, lichenase), an endo-acting glycoside hydrolase, specifically cleaves the beta-1,4 bond adjacent to a beta-1,3 bond, breaking high-molecular-weight beta-glucan into low-viscosity oligosaccharides. This improves filtration, boosts colloidal stability and releases nutrients. Starting from the viscosity bottleneck, this article explains the molecular mechanism, microbial sources, performance windows, technical route comparison and industrialization challenges, and gives a selection logic for R&D and procurement.
November 3, 2026
Alpha-acetolactate decarboxylase (alpha-ALDC, EC 4.1.1.5) is a metal-dependent carboxy-lyase that directly decarboxylates alpha-acetolactate to acetoin, bypassing the diacetyl (2,3-butanedione) pathway and thereby shortening beer maturation. Starting from the buttery diacetyl pain point, this article explains the molecular mechanism, catalytic properties and industrial parameters, compares yeast engineering and physical control routes, and offers selection and process guidance for R&D and procurement.
November 3, 2026
Transglutaminase (TGase, EC 2.3.2.13) is a transferase that catalyzes covalent cross-linking between proteins by forming ε-(γ-glutamyl)lysine isopeptide bonds, stitching dispersed proteins into a dense network. Microbial mTG, with weak calcium dependence, broad pH/temperature stability, wide availability and low cost, is the core enzyme for restructured meat, surimi gel, dairy and plant-protein processing. Using a dual-track explanation, this article first clarifies the concept in plain terms, then dives into molecular mechanism and process parameters, offering selection logic for R&D and procurement.
November 3, 2026
A generative protein design platform combines generative AI (diffusion models, transformer structure generators, protein language models) with high-throughput wet-lab validation, searching sequence/structure space along the fitness landscape and iterating through a "generate—score—screen—retrain" dry–wet closed loop. This article unpacks its background, principles, assay/selection and workflows, and explains how MatwingsVenus® turns generative design into a deliverable protein-engineering tool.
November 3, 2026
Scan to join community